Jeffrey Apter - Concepedia

Author

Jeffrey Apter

Pharmacology Research Institute

Also Known As

J T Apter, J. Apter, J. Long, J.T. Apter, Jeffrey Apter, Jeffrey T Apter, Jeffrey T. Apter

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Pharmacology Research Institute Rutgers, The State University of New Jersey Massachusetts General Hospital University Medical Center of Princeton Eli Lilly (United States)

About

Jeffrey Apter is an author at Pharmacology Research Institute specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	509
2	Social Sciences	7	7	492
3	Health Sciences	1	1	17
4	Endocrinology	1	1	39
5	Neurology	1	1	40

Jeffrey Apter

Publications

Citations

H-Index

Page 1

	Year	Citations
Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression Mark S. Kramer, Andrew Winokur, Jeffrey E. Kelsey, Neuropsychopharmacology PsychiatryFunctional SelectivityMedicinePsychotropic MedicationReceptor Antagonist	2003	258
Fluoxetine Treatment of Patients With Major Depressive Disorder Who Failed Initial Treatment With Sertraline Michael E. Thase, Sharon L. Blomgren, Martin Birkett, The Journal of Clinical Psychiatry	1997	204
Interruption of selective serotonin reuptake inhibitor treatment David Michelson, Maurizio Fava, Jay D. Amsterdam, The British Journal of Psychiatry	2000	179
Combined Treatment With Sertraline and Liothyronine in Major Depression Rena Cooper‐Kazaz, Jeffrey Apter, Revital Cohen, Archives of General Psychiatry	2007	108
Placebo-Controlled, Multicenter Study of Sertraline Treatment for Obsessive-Compulsive Disorder Michael H. Kronig, Jeffrey Apter, Gregory M. Asnis, Journal of Clinical Psychopharmacology PsychiatryAddictionPsychotropic MedicationObsessive-compulsive DisorderSertraline Treatment	1999	81
The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients Donna D. Walczak, Jeffrey Apter, James A. Halikas, Annals of Clinical Psychiatry Psychotropic MedicationPsychopharmacologyPharmacotherapyMental HealthSocial Sciences	1996	47
O1–06–05: The novel BACE inhibitor MK‐8931 dramatically lowers CSF beta‐amyloid in patients with mild‐to‐moderate Alzheimer's disease Mark S. Forman, Huub‐Jan Kleijn, Marissa F. Dockendorf, Alzheimer s & Dementia Placebo AdministrationDose-response ProfilesNeurochemical BiomarkersPharmacotherapyMild‐to‐moderate Alzheimer	2013	40
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment David Michelson, Jay D. Amsterdam, Jeffrey Apter, Psychoneuroendocrinology Stress HormonePsychiatryStressMedicineSelective Serotonin	2000	39
Affective-Cognitive Behavioral Therapy for Fibromyalgia: A Randomized Controlled Trial Robert L. Woolfolk, Lesley A. Allen, Jeffrey Apter Pain Research and Treatment Pain TherapyPain MedicineNeuropathic PainMental HealthFibromyalgia	2011	17
Bupropion/Nortriptyline Combination for Refractory Depression Jeffrey Apter, Stuart Kushner, Robert L. Woolfolk Annals of Clinical Psychiatry PsychiatryNewer Agent BupropionMedicinePsychotropic MedicationDepression	1994	15

Page 1